跳至主要内容
临床试验/NCT01430806
NCT01430806Unknown不适用

Dronedarone for Patients With Recurrent ICD Shocks Due to Ventricular Arrhythmia Resistant to Their Antiarrhythmic Drug Therapy or Ablation

Rabin Medical Center0 个研究点目标入组 20 人开始时间: 2011年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
20
主要终点
Number of ICD shocks due to VT in the 6 months period after starting Dronedarone

研究概览

简要总结

Recurrent ICD shocks are a serious problem in pts with ICD. Treatment failure with other antiarrhythmics and ablation are common. Dronedarone is a new antiarrhythmic drug with ion channel properties similar to amiodarone.

Several case reports have shown promising results with Dronedarone for this patient population.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Recurernt ICD shocks depite other antiarrhythmic drug therapy

排除标准

  • CHF NYHA IV OR DECMPENSATED III
  • PERMANENT AF
  • LIVER DYSFUNCION
  • CR CLEARANCE <30

研究组 & 干预措施

Dronedrone Arm

Other

干预措施: Dronedarone (Drug)

Dronedrone Arm

Other

干预措施: Dronedarone arm (Drug)

结局指标

主要结局

Number of ICD shocks due to VT in the 6 months period after starting Dronedarone

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

moti haim

Director, Electrophysiology Service,

Rabin Medical Center

相似试验